本页面由Tiger Trade Technology Pte. Ltd.提供服务

4D Molecular Therapeutics

15.83
-0.2700-1.68%
盘后15.43-0.4000-2.53%19:30 EDT
成交量:92.12万
成交额:1,468.41万
市值:8.75亿
市盈率:-5.74
高:16.91
开:16.32
低:15.33
收:16.10
52周最高:16.93
52周最低:5.97
股本:5,524.42万
流通股本:4,201.62万
量比:0.45
换手率:2.19%
股息:- -
股息率:- -
每股收益(TTM):-2.7580
每股收益(LYR):-2.4200
净资产收益率:-43.25%
总资产收益率:-25.09%
市净率:2.15
市盈率(LYR):-6.54

数据加载中...

2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/20

重要事件披露

Form 8-K - Current report
2026/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

SEC问询函

Form CORRESP - Correspondence